First Header Logo Second Header Logo

A multicentre international randomized parallel group double-blind placebo-controlled clinical trial of EMPAgliflozin once daily to assess cardio-renal outcomes in patients with chronic KIDNEY disease


Collapse Biography 

Collapse Time 
Collapse start date
2019-09-01
Collapse end date
2023-08-31